Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis

Epidemiological and biochemical data suggest a link between the cholesterol metabolism, the amyloid precursor protein (APP) processing and the increased cerebral beta-amyloid (Abeta) deposition in Alzheimer's disease (AD). The individual and combined effects of a high-cholesterol (HC) diet and the overexpression of the human apoB-100 gene were therefore examined on the cerebral expression and processing of APP in homozygous apoB-100 transgenic mice [Tg (apoB(+/+))], a validated model of atherosclerosis. When fed with 2% cholesterol for 17 weeks, only the wild-type mice exhibited significantly increased APP695 (123%) and APP770 (138%) mRNA levels in the cortex. The HC diet-induced hypercholesterolemia significantly increased the APP isoform levels in the membrane-bound fraction, not only in the wild-type animals (114%), but also in the Tg apoB(+/+) group (171%). The overexpression of human apoB-100 gene by the liver alone reduced the brain APP isoform levels in the membrane-bound fraction (78%), whereas the levels were increased by the combined effect of HC and the overexpression of the human apoB-100 gene (134%). The protein kinase C and beta-secretase protein levels were not altered by the individual or combined effects of these two factors. Our data indicate that the two atherogenic factors, the HC diet and the overexpression of the human apoB-100 gene by the liver, could exert different effects on the processing and expression of APP in the mice brain.

[1]  J. Palacios,et al.  Increased levels of the Kunitz protease inhibitor-containing beta APP mRNAs in rat brain following neurotoxic damage. , 1993, Brain research. Molecular brain research.

[2]  S. Shimohama,et al.  Trophic effect of beta-amyloid precursor protein on cerebral cortical neurons in culture. , 1991, Biochemical and biophysical research communications.

[3]  Rudolph E. Tanzi,et al.  Alzheimer's disease: the cholesterol connection , 2003, Nature Neuroscience.

[4]  J. Hardy,et al.  Apolipoprotein E alleles but neither apolipoprotein B nor apolipoprotein AI/CIII alleles are associated with late onset, familial Alzheimer's disease , 1995, Neuroscience Letters.

[5]  G. Celesia,et al.  Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. , 2000, Archives of neurology.

[6]  R. Doms,et al.  Protein Kinase C-dependent α-Secretase Competes with β-Secretase for Cleavage of Amyloid-β Precursor Protein in the Trans-Golgi Network* , 2000, The Journal of Biological Chemistry.

[7]  P. Ianna,et al.  Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. , 1997, The Biochemical journal.

[8]  D. Sparks,et al.  Cholesterol and Cognition , 2002 .

[9]  W. Klein,et al.  Cholesterol Modulates -Secretase Cleavage of Amyloid Precursor Protein (*) , 1996, The Journal of Biological Chemistry.

[10]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[11]  P. Ferdinandy,et al.  Cholesterol and cholesterol plus DHA diet-induced gene expression and fatty acid changes in mouse eye and brain. , 2004, Biochimie.

[12]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[13]  G. Forloni,et al.  Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway. , 2000, The Biochemical journal.

[14]  S. Young,et al.  Transgenic mice expressing both human apolipoprotein B and human CETP have a lipoprotein cholesterol distribution similar to that of normolipidemic humans. , 1995, Journal of lipid research.

[15]  D. Sparks,et al.  Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. , 2005, Archives of general psychiatry.

[16]  D. Sparks,et al.  Is there a characteristic lipid profile in Alzheimer's disease? , 2005, Journal of Alzheimer's disease : JAD.

[17]  K. Fukuchi,et al.  Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. , 2003, The American journal of pathology.

[18]  G. Balogh,et al.  Hyperlipidemia induced by high cholesterol diet inhibits heat shock response in rat hearts. , 2002, Biochemical and biophysical research communications.

[19]  J. Breslow.  Mouse Models of Atherosclerosis , 1996, Science.

[20]  B. Austen,et al.  Post‐translational processing of beta‐secretase in Alzheimer's disease , 2005, Proteomics.

[21]  M. Lees,et al.  A linear Lowry--Folin assay for both water-soluble and sodium dodecyl sulfate-solubilized proteins. , 1978, Analytical biochemistry.

[22]  Andreas Weidemann,et al.  Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein , 1989, Cell.

[23]  G. Eckert,et al.  Brain cholesterol, statins and Alzheimer's Disease. , 2003, Pharmacopsychiatry.

[24]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[25]  K. Ikeda,et al.  Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's disease , 1992, Neuroscience Letters.

[26]  M. Mattson,et al.  Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein , 1993, Neuron.

[27]  R. Nitrini,et al.  Increased apolipoprotein B serum concentration in Alzheimer's disease , 1999, Acta neurologica Scandinavica.

[28]  B. Strooper,et al.  Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  David Bouchez,et al.  Manipulating the Mouse Embryo , 2007 .

[30]  D. Sparks,et al.  Cholesterol Accumulates in Senile Plaques of Alzheimer Disease Patients and in Transgenic APPsw Mice , 2001, Journal of neuropathology and experimental neurology.

[31]  M. Callow,et al.  Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. E. Pitas,et al.  Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. , 1987, The Journal of biological chemistry.

[33]  D. Sparks,et al.  Intraneuronal β-amyloid immunoreactivity in the CNS , 1996, Neurobiology of Aging.

[34]  B. Winblad,et al.  Quantification of APP and APLP2 mRNA in APOE genotyped Alzheimer's disease brains. , 1996, Brain research. Molecular brain research.

[35]  B. Greenberg,et al.  Modulation of Secreted β-Amyloid Precursor Protein and Amyloid β-Peptide in Brain by Cholesterol* , 1998, The Journal of Biological Chemistry.

[36]  S. Young,et al.  Genetically modified mice for the study of apolipoprotein B. , 1998, Journal of lipid research.

[37]  P. Nastalek,et al.  Mouse models of experimental atherosclerosis. , 2004, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[38]  G. Multhaup,et al.  Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. , 1988, The EMBO journal.